Nothing Special   »   [go: up one dir, main page]

Bader et al., 2005 - Google Patents

Inhibition of protein synthesis by Y box-binding protein 1 blocks oncogenic cell transformation

Bader et al., 2005

View HTML
Document ID
10474358663403730156
Author
Bader A
Vogt P
Publication year
Publication venue
Molecular and cellular biology

External Links

Snippet

The multifunctional Y box-binding protein 1 (YB-1) is transcriptionally repressed by the oncogenic phosphoinositide 3-kinase (PI3K) pathway (with P3K as an oncogenic homolog of the catalytic subunit) and, when reexpressed with the retroviral vector RCAS, interferes …
Continue reading at www.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Similar Documents

Publication Publication Date Title
Bader et al. Inhibition of protein synthesis by Y box-binding protein 1 blocks oncogenic cell transformation
Kudo et al. Molecular cloning and cell cycle-dependent expression of mammalian CRM1, a protein involved in nuclear export of proteins
Korgaonkar et al. Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function
Fernández-Salas et al. mtCLIC/CLIC4, an organellular chloride channel protein, is increased by DNA damage and participates in the apoptotic response to p53
Shattuck et al. LRIG1 is a novel negative regulator of the Met receptor and opposes Met and Her2 synergy
Hu et al. S and G2 phase roles for Cdk2 revealed by inducible expression of a dominant-negative mutant in human cells
Sen et al. Regulation of SRC family kinases in human cancers
Gu et al. ei24, a p53 response gene involved in growth suppression and apoptosis
Pyndiah et al. c-MYC suppresses BIN1 to release poly (ADP-ribose) polymerase 1: a mechanism by which cancer cells acquire cisplatin resistance
Wang et al. Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase
Huang et al. Postrepression activation of NF-κB requires the amino-terminal nuclear export signal specific to IκBα
Cho et al. The dual-specificity phosphatase CDC14B bundles and stabilizes microtubules
Zhu et al. MCG10, a novel p53 target gene that encodes a KH domain RNA-binding protein, is capable of inducing apoptosis and cell cycle arrest in G2-M
Kurisu et al. MDG1/ERdj4, an ER‐resident DnaJ family member, suppresses cell death induced by ER stress
Suzuki et al. Involvement of the Polycomb-group gene Ring1B in the specification of the anterior-posterior axis in mice
de la Fuente et al. Overexpression of p21waf1 in human T-cell lymphotropic virus type 1-infected cells and its association with cyclin A/cdk2
Munarriz et al. PIAS-1 is a checkpoint regulator which affects exit from G1 and G2 by sumoylation of p73
Parsons Discovery of the PTEN tumor suppressor and its connection to the PI3K and AKT oncogenes
Zhang et al. Parafibromin inhibits cancer cell growth and causes G1 phase arrest
Datta et al. Differential regulation of E2F1, DP1, and the E2F1/DP1 complex by ARF
Thyssen et al. LZTS2 is a novel β-catenin-interacting protein and regulates the nuclear export of β-catenin
Huang et al. Drosophila Smt3 negatively regulates JNK signaling through sequestering Hipk in the nucleus
AU775583B2 (en) Methods for the diagnosis and treatment of metastatic prostate tumors
Jia et al. Identification and characterization of hic-5/ARA55 as an hsp27 binding protein
Liu et al. A critical role for cyclin C in promotion of the hematopoietic cell cycle by cooperation with c-Myc